Trail-blazing social entrepreneurs are tackling the world’s most pressing problems that government, business, or charity have failed to solve. They are creating businesses with a primary mission of social change. Scott Boyer is one such social entrepreneur. This 28-year veteran of Big Pharma left a six-figure salary to start OWP Pharmaceuticals and the ROW Foundation. This commercial business and non-profit organization exist in a symbiotic relationship we call a "tandem hybrid social enterprise." This model combines a multimillion dollar business with a foundation that’s on track to become the largest funder of projects serving people with epilepsy and associated psychiatric disorders in the world.

The tandem hybrid incorporates the principles learned by Scott and others for building a truly unique social enterprise from the ground up; one that is:

  • Driven by a compelling social mission
  • Financed by commercial success
  • Structured to retain control
  • Scalable and sustainable for the long haul

Powering Social Enterprises With Profit And Purpose offers a detailed blueprint that has proven commercially and philanthropically successful and that can be replicated in most business sectors.

part I|50 pages

Commercial and Social Enterprises

chapter 1|11 pages

For Profit

Commercial Enterprises

chapter 2|13 pages

For Purpose

Social Enterprises

chapter 3|13 pages

Combining Profit and Purpose

Hybrid Social Enterprises

chapter 4|11 pages

The Next Level

Tandem Hybrid Social Enterprises

part II|50 pages

Building Tandem Hybrid Social Enterprises

chapter 5|10 pages

Driven by a Compelling Social Mission

chapter 6|13 pages

Financed by Commercial Success

chapter 7|12 pages

Structured to Retain Control

chapter 8|13 pages

Scalable and Sustainable for the Long Haul

part III|68 pages

Lessons from History

chapter 9|16 pages

The Hershey Company and Mars Inc.

chapter 10|16 pages

Hormel Foods Corporation and Tyson Foods

chapter 11|17 pages

H. Lundbeck & Co and Novo Nordisk

chapter 12|17 pages

AstraZeneca and the Upjohn Company

part IV|15 pages

A Call to Action

chapter 13|13 pages

Move the Needle

How You Can Advance the Social Enterprise Movement